MIR 2014: Tracking Radiation Dose
The paradox is that the move to personalisation of medicine means variability. However, quantitative imaging requires standardisation, reproducibility, consistency and quality.
The solution is accepting the variations of patient age, sex (imaging is no longer gender neutral) and size, clinical context and the available technology. Tracking is needed. Variation in contrast media usage and radiation dose should be rejected if it is not clinically justified. Tracking should be systematic, comprehensive, shared and acted upon. Caramella noted the Quantative Imaging Biomarkers Alliance (QIBA) that aims to reduce variability across devices, patients and time. A study by Caramella’s team in Pisa, for example, found that variation in dose depended on the technician involved and the radiologist. Radiologists therefore need to extract the relevant non-image biomarkers. Tracking will allow extraction of trends, benchmarking and sustainability - the latter is not just an economic concept.
Training is extremely important, as is the legal environment. The European Council Directive 2013/59/EURATOM lays down the basic safety standards for protection against the dangers arising from exposure to ionising radiation. Article 60 decrees that “any equipment used for interventional radiology and computed tomography and any new equipment used for planning, guiding and verification purposes has a device or a feature informing the practitioner, at the end of the procedure, of relevant parameteters for assessing the patient dose.” In addition, the equipment should have the capability of transferring this information in the record of the examination. Article 58 of the directive states that information relevant to the patient exposure forms part of the report of the medical radiological procedure. The main changes in this directive compared to previous ones is the provision regarding information relating to patient exposure and the transfer of dose information. The directive requires member states to adapt their laws and regulations by February 2018. The European Society of Radiology has an important role to play in supporting its implementation through professional channels. The EuroSafe campaign was launched last year.
However, said Caramella, radiology services need to analyse what they do. In Italy, a questionnaire distributed to over 500 radiographers found a lack of education. A worrying 56.4% seldom and 31.7% never attended training on radiation safety. Only 12% had participated in such training. In addition, few of the respondents had correct knowledge about radiation safety.
Concluded Caramella, “Don’t relax, assuming everything is ok.” Tracking is needed, and the information is already in PACS and transparent.
Managing Editor, HealthManagement
Published on : Sun, 12 Oct 2014
FUJIFILM combines forces with Medcom's BiopSee, allowing stereotactic navigation for targeted biopsy & therapy guidance, powered by ultrasound and magnetic resonance image fusion.
UltraDrape is an innovative dressing designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) that provides dual-action barrier and securement in one.
Open high-field efficiency with patient-centric architecture OASIS™ is a new generation of MR systems, providing a high degree of diagnostic confidence and extraordinary patient comfort. With this unique scanner, Hitachi combines best high-field performance...
The next level in usability ARIETTA 50LE is the compact entry model of the ARIETTA series, inviting easy operation from beginners through experts, taking you to the ‘next level’. This ultrasound platform combines Carefree Workflow, Clear...
BioZorb® 3D Bioabsorbable Marker The BioZorb® is a 3D implantable marker that consists of a spiral, bioabsorbable framework embedded with 6 permanent, titanium clips designed to precisely mark your surgical excision site. Designed to improve outcomes...